Order Article Reprints

Gonzalez Guzman LA, García Robaina JC, Barrios Recio J, Escudero Arias E, Liñares Mata T, Cervera Aznar R, De La Roca Pinzón F, Miguel Polo LdC, Arenas Villarroel L, López Couso VP, et al. Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy. Vaccines. 2023; 11(5):979. https://doi.org/10.3390/vaccines11050979

Gonzalez Guzman, Luis Alfredo, Jose Carlos García Robaina, Javier Barrios Recio, Elena Escudero Arias, Tania Liñares Mata, Raquel Cervera Aznar, Federico De La Roca Pinzón, Lissette del Carmen Miguel Polo, Luis Arenas Villarroel, Verónica P. López Couso, and et al. 2023. "Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy" Vaccines 11, no. 5: 979. https://doi.org/10.3390/vaccines11050979

Gonzalez Guzman, L. A., García Robaina, J. C., Barrios Recio, J., Escudero Arias, E., Liñares Mata, T., Cervera Aznar, R., De La Roca Pinzón, F., Miguel Polo, L. d. C., Arenas Villarroel, L., López Couso, V. P., Alcover Diaz, J., Rodriguez Gil, D., Pelaez, R. P., & Carballada Gonzalez, F. J. (2023). Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy. Vaccines, 11(5), 979. https://doi.org/10.3390/vaccines11050979